Related Experiment Video
Updated: Nov 15, 2025

Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine
Published on: January 25, 2019
Conserved nicotine-activated neuroprotective pathways involve mitochondrial stress.
J Brucker Nourse1, Gilad Harshefi2, Adi Marom2
1Department of Biological Sciences, The University of Alabama, Tuscaloosa, 35487 AL, USA.
Nicotine protects Parkinson's disease-vulnerable neurons by activating specific receptors and a mitochondrial stress pathway. This pathway involves D3-receptors, PTEN-induced kinase 1 (PINK1), and Parkin, offering neuroprotection.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Tobacco smoking is linked to various diseases but paradoxically reduces Parkinson's disease (PD) prevalence.
- Parkinson's disease is characterized by the degeneration of dopaminergic neurons (DNs) in the substantia nigra.
- Nicotine, a tobacco component, may offer neuroprotective effects through nicotinic acetylcholine receptors (nAChRs).
Purpose of the Study:
- To investigate if nicotine activates nAChRs to selectively protect dopaminergic neurons (DNs).
- To elucidate the molecular mechanisms underlying nicotine-mediated neuroprotection in a model organism.
Main Methods:
- Utilized *Caenorhabditis elegans* (*C. elegans*) as a model organism.
- Investigated the role of conserved DN-expressed nAChRs and associated genes in nicotine's protective effects.
- Examined the involvement of DOP-2 (D3-receptor homolog), MCU-1 (mitochondrial calcium uniporter), PTEN-induced kinase 1 (PINK1), and Parkin (PDR-1).
Main Results:
- Demonstrated conserved functions of DN-expressed nAChRs in *C. elegans*.
- Identified DOP-2, MCU-1, PINK1, and PDR-1 as essential for nicotine-mediated protection of DNs.
- Supported the involvement of a calcium-modulated, mitochondrial stress-activated PINK1/Parkin pathway in neuroprotection.
Conclusions:
- Nicotine selectively protects substantia nigra DNs through a combination of factors.
- These factors include DNs' vulnerability to mitochondrial stress and their specific expression of D3-receptors.
- Activation of PINK1 enhances mitochondrial quality control, mitigating stress and providing neuroprotection.
More Related Videos
12:19Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons
Published on: June 24, 2015
08:47Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Depressants: Alcohol and Nicotine
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Neurochemical Transmission: Sites of Drug Action
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Affecting Neurotransmitter Synthesis